Richard A. Graham - Nov 14, 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, RESEARCH & DEVELOPMENT
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 14, 2023
Transactions value $
-$25,366
Form type
4
Date filed
11/16/2023, 06:16 PM
Previous filing
Nov 1, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale -$25.4K -2.48K -0.71% $10.22 347K Nov 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.